Evidence map›Paper›PMID 23565872›Full record

ArticleJournal of biomaterials science. Polymer edition2013

Dense chitosan surgical membranes produced by a coincident compression-dehydration process.

Thomas P Dooley, April L Ellis, Maria Belousova, Don Petersen, Arthur A DeCarlo

Abstract read
In one paragraph

Article in Journal of biomaterials science. Polymer edition, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Thomas P DooleyAgenta Biotechnologies Inc, 1500 1st Avenue North, Unit 31, Birmingham, AL 35203, USA. dooley@agentabio.com
April L Ellis
Maria Belousova
Don Petersen
Arthur A DeCarlo

Funding

Molecular Heparan Sulfate Delivery in Guided Tissue RegenerationR44DE017254 · NIDCR · AGENTA BIOTECHNOLOGIES, INC. · PI DECARLO, ARTHUR A · 2009 to 2010
$1.1M
Molecular Heparan Sulfate Delivery in Guided Tissue RegenerationR43DE017254 · NIDCR · AGENTA BIOTECHNOLOGIES, INC. · PI DECARLO, ARTHUR A · 2007 to 2007
$94k
NIDCR NIH HHS DE017254NIDCR NIH HHS R43 DE017254NIDCR NIH HHS R44 DE017254
6 · The paper itself

Abstract

High density chitosan membranes were produced via a novel manufacturing process and used as implantable resorbable surgical membranes. The innovative method utilizes the following three sequential steps: (1) casting an acidic chitosan solution within a silicon mold, followed by freezing; (2) neutralizing the frozen acidic chitosan solution in alkaline solution to facilitate polymerization; and (3) applying coincident compression-dehydration under a vacuum. Resulting membranes of 0.2-0.5 mm thickness have densities as high as 1.6 g/cm(3). Inclusion of glycerol prior to the compression-dehydration step provides additional physical and clinical handling benefits. The biomaterials exhibit tensile strength with a maximum load as high as 10.9 N at ~2.5 mm width and clinically relevant resistance to suture pull-out with a maximum load as high as 2.2 N. These physical properties were superior to those of a commercial reconstituted collagen membrane. The dense chitosan membranes have excellent clinical handling characteristics, such as pliability and 'memory' when wet. They are semipermeable to small molecules, biodegradable in vitro in lysozyme solution, and the rates of degradation are inversely correlated to the degree of deacetylation. Furthermore, the dense chitosan membranes are biocompatible and resorbable in vivo as demonstrated in a rat oral wound healing model. The unique combination of physical, in vitro, in vivo, and clinical handling properties demonstrate the high utility of dense chitosan membranes produced by this new method. The materials may be useful as surgical barrier membranes, scaffolds for tissue engineering, wound dressings, and as delivery devices for active ingredients.

Indexed as

Membranes, ArtificialAnimalsBiocompatible MaterialsCell LineChitosanHumansMaleMaterials TestingMuramidasePermeabilityRatsRats, Inbred LewTensile StrengthWound HealingBiocompatible MaterialsChitosanMembranes, ArtificialMuramidase

Identifiers

PMID23565872
PMCPMC3623014

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.